Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Sequent Scientific LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:512529 NSE Symbol: SEQUENT P/E (TTM) :0
ISIN Demat:INE807F01027 Div & Yield %:0 EPS (TTM) :0.06
Book Value (RS) :42.6256986 Market Cap (Rs Cr.):3054.31 Face Value (RS) :2
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.020.010.020.040.02
Long Term Debt-Equity Ratio0.000.000.010.020.01
Current Ratio1.741.761.341.132.07
Fixed Assets2.002.042.632.633.00
Inventory3.843.866.888.018.49
Debtors6.743.865.195.432.74
Interest Cover Ratio-2.8810.7516.255.532.93
PBIDTM (%)0.8412.2419.8516.1910.01
PBITM (%)-3.257.8816.4112.255.67
PBDTM (%)-0.2811.5118.8413.978.07
CPM (%)1.3711.1115.5413.328.91
APATM (%)-2.736.7412.109.394.57
ROCE (%)-0.681.654.342.790.92
RONW (%)-0.581.433.272.230.76

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)